The Cigna Group (NYSE:CI) Shares Bought by XTX Topco Ltd

XTX Topco Ltd raised its holdings in The Cigna Group (NYSE:CI) by 461.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,420 shares of the health services provider’s stock after purchasing an additional 2,811 shares during the period. XTX Topco Ltd’s holdings in The Cigna Group were worth $1,131,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Altrius Capital Management Inc lifted its stake in The Cigna Group by 1.9% in the 2nd quarter. Altrius Capital Management Inc now owns 13,728 shares of the health services provider’s stock valued at $4,538,000 after buying an additional 251 shares in the last quarter. Blair William & Co. IL lifted its position in shares of The Cigna Group by 2.1% in the second quarter. Blair William & Co. IL now owns 44,534 shares of the health services provider’s stock valued at $14,721,000 after acquiring an additional 935 shares in the last quarter. Vanguard Personalized Indexing Management LLC lifted its position in shares of The Cigna Group by 12.2% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 30,347 shares of the health services provider’s stock valued at $9,663,000 after acquiring an additional 3,301 shares in the last quarter. Meiji Yasuda Asset Management Co Ltd. boosted its stake in shares of The Cigna Group by 10.9% in the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 4,754 shares of the health services provider’s stock worth $1,572,000 after acquiring an additional 468 shares during the last quarter. Finally, Argent Trust Co increased its position in shares of The Cigna Group by 3.0% during the second quarter. Argent Trust Co now owns 3,877 shares of the health services provider’s stock worth $1,282,000 after purchasing an additional 114 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

The Cigna Group Trading Down 0.3 %

Shares of CI stock opened at $356.14 on Friday. The Cigna Group has a 1-year low of $253.95 and a 1-year high of $370.83. The firm has a market cap of $101.17 billion, a PE ratio of 29.24, a price-to-earnings-growth ratio of 1.09 and a beta of 0.50. The company has a 50-day moving average of $347.02 and a two-hundred day moving average of $344.97. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.71 and a quick ratio of 0.71.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, August 1st. The health services provider reported $6.72 earnings per share for the quarter, topping analysts’ consensus estimates of $6.42 by $0.30. The firm had revenue of $60.52 billion during the quarter, compared to analysts’ expectations of $58.30 billion. The Cigna Group had a net margin of 1.70% and a return on equity of 17.83%. The firm’s quarterly revenue was up 24.6% on a year-over-year basis. During the same quarter last year, the company posted $6.13 EPS. On average, analysts predict that The Cigna Group will post 28.48 EPS for the current year.

The Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 19th. Investors of record on Wednesday, September 4th were paid a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a yield of 1.57%. The ex-dividend date of this dividend was Wednesday, September 4th. The Cigna Group’s payout ratio is 45.98%.

Insider Activity at The Cigna Group

In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the business’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the sale, the director now directly owns 17,539 shares in the company, valued at $6,010,264.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Brian C. Evanko sold 4,795 shares of the business’s stock in a transaction on Monday, June 24th. The stock was sold at an average price of $345.01, for a total transaction of $1,654,322.95. Following the completion of the transaction, the insider now directly owns 39,923 shares of the company’s stock, valued at approximately $13,773,834.23. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William J. Delaney III sold 2,691 shares of the stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the completion of the sale, the director now directly owns 17,539 shares in the company, valued at approximately $6,010,264.52. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CI has been the topic of a number of research reports. Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 price objective on shares of The Cigna Group in a report on Monday, September 16th. JPMorgan Chase & Co. boosted their price target on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 21st. Baird R W upgraded shares of The Cigna Group to a “strong-buy” rating in a report on Thursday, May 30th. Stephens restated an “overweight” rating and set a $410.00 target price on shares of The Cigna Group in a report on Friday, August 2nd. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $384.00 price target on shares of The Cigna Group in a research report on Monday, September 9th. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, The Cigna Group currently has an average rating of “Buy” and a consensus target price of $392.79.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.